Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

The pharma and life sciences sector is undergoing accelerated transformation, driven by scientific progress, shifting markets and a renewed focus on equitable innovation. This edition reflects that momentum, highlighting how leading organisations are redefining their roles within a fast-changing landscape. First, the recognition of ‘Bristol Myers Squibb Wins Pharma Industry Company of the Year at the Pharma Industry Awards 2025’ underscores a sector raising its performance standards. The accolade shows how strategic investment, pipeline development and operational discipline are reinforcing long-term competitiveness. Market dynamics are also evolving. ‘Eli Lilly reaches the trillion dollar milestone as weight loss drugs reshape pharma’ signals how breakthrough treatments are recalibrating valuation models and reshaping expectations for innovation and commercial agility. Workplace leadership continues to shift. ‘EmpowHER: Women Driving Change and Innovation at SGS Pharma’ demonstrates how talent diversification is becoming essential to organisational strength. Inclusive leadership is broadening the industry's capacity to respond to complex health needs. Each piece in this edition traces a sector redefining its direction while keeping sight of sustainable, patient-centred progress. Readers are encouraged to explore these developments for deeper insight into the forces shaping pharma’s future.

Author: Jed Nykolle Harme

Bristol Myers Squibb was named Pharma Industry Company of the Year at the recently concluded Pharma Industry Awards 2025, setting benchmarks for innovation and inspiring entries for 2026.

Author: Jed Nykolle Harme

Women at SGS are leading the way in pharmaceutical innovation, combining expertise, leadership, and collaboration to shape the future of the life sciences industry. At SGS Pharma, diversity and inclusion are more than guiding principles, they are drivers of scientific excellence.

Author: Investing.com

Citadel Group disclosed a 1.64% stake and 1.13% short position in Avadel Pharmaceuticals, detailing share trades and extensive options holdings in a mandatory Form 8.3 filing under Irish Takeover Panel rules.

Author: European Pharmaceutical Review

UK medicines manufacturing receives a £54m sustainability investment through Innovate UK’s SMMIP, funding R&D projects focused on automation, digitalisation and greener production, with CPI and major pharma partners driving efficiency, competitiveness and decarbonisation efforts.

Author: ALJAZEERA

Eli Lilly becomes the first drugmaker worth $1 trillion as surging demand for obesity drugs fuels record revenue, rapid stock gains, and industry-leading growth driven by Mounjaro, Zepbound, and upcoming GLP-1 innovations.

Author: The Irish Times

Irish goods exports surged 27.8% in September, driven by pharmaceutical growth and soaring US demand, reinforcing Ireland’s strong trade surplus, export resilience, and rising dependence on chemicals and medical products.

Author: Archie Villaflores

Investment, research focus, and competition are shifting across pharma as companies refine strategies that respond to scientific progress and market pressure. This edition brings those movements into clearer view, guided by one idea: leadership that adapts with purpose. The opening feature, Women in Pharma Awards 2026 opens entries to recognise industry leaders, points to how talent development and leadership visibility influence long-term resilience. Recognition programmes signal that organisations are reassessing how capability, diversity, and accountability shape performance. Keenova completes spinout of Par Health and rebrands from Mallinckrodt adds a view of restructuring that reflects broader trends in portfolio management and capital discipline. Businesses are seeking sharper clinical focus and operational clarity, responding to regulatory scrutiny and investor expectation. Novo Nordisk India launches Poviztra with Emcure Pharma shows how established players continue to strengthen therapeutic pipelines through targeted partnerships that expand reach and delivery capacity. These stories mark a period defined by strategic recalibration, closer collaboration, and an appetite for models that support sustainable growth. See how each development contributes to a sector moving with intent, supported by innovation and steady investment in capability.

Author: Archie Villaflores

Entries are now open for the Women in Pharma Awards 2026, honouring outstanding women driving innovation, excellence, and leadership across Ireland’s pharmaceutical landscape.

Author: DealStreetAsia

Rome-based Angelini Ventures has opened its first Asia office in Singapore to support biotech and healthtech innovation. The expansion will strengthen collaboration with local startups and enhance investment opportunities in pharmaceutical and digital health ventures.